# A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

> **NCT07753226** · PHASE1 · RECRUITING · sponsor: **Sichuan Baili Pharmaceutical Co., Ltd.** · enrollment: 39 (estimated)

## Conditions studied

- Breast Cancer
- Solid Tumor

## Interventions

- **DRUG:** SI-B036

## Key facts

- **NCT ID:** NCT07753226
- **Lead sponsor:** Sichuan Baili Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-18
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753226, "A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*